These findings indicate that SIRT3 expression prevents ROS production, autophagy, and apoptosis, as well as increases cell viability and survival of breast cancer cells, thus demonstrating a tumor-promoting effect. This evidence concerns the gene SIRT3 and breast carcinoma.